Home Biosimilar Antibodies Neuronal Signaling CGRP Receptor Eptinezumab (Anti-CALCA / CGRP)
For research use only. Not for use in humans.

Eptinezumab (Anti-CALCA / CGRP)

Synonyms: null

Eptinezumab (Anti-CALCA / CGRP) is a humanized monoclonal antibody that binds to calcitonin gene-related peptide (CGRP) and blocks its binding to the receptor. It is used in the preventive treatment of episodic migraine. MW: 143.36 kD.

Eptinezumab (Anti-CALCA / CGRP)

Quality Control

Batch: A279001 Purity: 99% Protein concentration: 7.163mg/ml Endotoxin Level: ＜1EU/mg
99

Specificity

Name Citation CGRP
Atogepant 0
Ubrogepant 0
Olcegepant 0
Vazegepant hydrochloride 0
Expand to Check More
1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation. 2. "✔" indicates inhibitory effect, but without specific value.

Mechanism of Action

Description
Eptinezumab (Anti-CALCA / CGRP) is a humanized monoclonal antibody that binds to calcitonin gene-related peptide (CGRP) and blocks its binding to the receptor. It is used in the preventive treatment of episodic migraine. MW: 143.36 kD.
References

Product Details

CAS No. 1644539-04-7
Molecular Weight 143.36
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100 mM Pro-Ac, 20mM Arg, pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.